Esperion Therapeutics, Inc. (ESPR)
3.125
0.00 (0.00%)
USD |
NASDAQ |
May 15, 16:00
3.12
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Total Assets (Quarterly) : 462.53M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 763.27M |
| Merck & Co., Inc. | 128.68B |
| Harrow, Inc. | 419.54M |
| Corcept Therapeutics, Inc. | 814.88M |
| Eli Lilly & Co. | 116.58B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 770.46M |
| Shareholders Equity (Quarterly) | -307.93M |
| Debt to Equity Ratio | -1.766 |
| Current Ratio | 1.530 |
| Net Debt Paydown Yield | 1.34% |